Post-earnings recap
Reported
Wed, Apr 30, 2025
EPS actual
$-0.53
EPS est.
$-0.33
EPS surprise
-63.08%
1-day move
-1.91%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's disappointing EPS results indicate ongoing struggles within the company. The stock fell by 1.91% following the announcement, reflecting investor concerns about profitability and market conditions. Without revenue figures or guidance, uncertainty remains about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.53 | N/A | -63.08% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about current market conditions impacting performance. They are prioritizing cost management and operational improvements.
Management acknowledged the ongoing challenges in the market.
They emphasized a focus on improving operational efficiency moving forward.